Treating Cancer with CBD

Cannabinoids are stepping into the ring to help fight cancer. SōRSE Technology Technology has acquired cancer drug development company Pascal Biosciences and its cannabinoid programs in a deal that values the joint companies at $60 million. SōRSE Technology CEO Howard Lee joined Cheddar to discuss.
We use cookies and similar technologies on this site to collect identifiers, such as IP address, and cookie and device IDs as described in our Privacy Policy.